European Medicines Agency: What’s at stake?

The European Medicines Agency offices in Canary Wharf, London. [Gordon Bell/Shutterstock]

Click here to download this Special Report.

Last month, EU Council President Donald Tusk and European Commission chief Jean-Claude Juncker presented the procedure for relocating the European Bank Authority (EBA) and the European Medicines Agency (EMA) from the UK after it leaves the EU.

The EMA is an EU regulatory authority which ensures that medicines available to 500 million citizens across Europe are appropriate and safe. Its office is currently in London but will need to be moved outside the UK because of Brexit.

Many suggest that this is the first test for the remaining 27 member states as crucial Brexit talks get underway. Will EU leaders manage to find a compromise solution and facilitate a smooth transition?

In this Special Report, EURACTIV.com examines the challenges faced by those directly involved or impacted by the decision.

Download PDF  

Subscribe to our newsletters

Subscribe